Boston Partners Johnson & Johnson Transaction History

Boston Partners

$90.9 Billion
Q3 2025

A detailed history of Boston Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Boston Partners holds 1,627,385 shares of JNJ stock, worth $325 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

1,627,385

Previous 1,698,781 4.2%

Holding current value

$325 Million

Previous $259 Million 16.29%

% of portfolio

0.33%

Previous 0.31%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$155.17 - $185.42 $11.1 Million - $13.2 Million	-71,396 Reduced 4.2%	1,627,385 $302 Million
Q2 2025 Aug 12, 2025	BUY	$146.36 - $159.82 $696,380 - $760,423	4,758 Added 0.28%	1,698,781 $259 Million
Q2 2025 Aug 07, 2025	SELL	$146.36 - $159.82 $9.55 Million - $10.4 Million	-65,272 Reduced 3.71%	1,694,023 $259 Million
Q1 2025 May 12, 2025	SELL	$142.06 - $167.7 $71.6 Million - $84.5 Million	-503,772 Reduced 22.26%	1,759,295 $292 Million
Q4 2024 Feb 10, 2025	BUY	$143.34 - $165.86 $62.2 Million - $71.9 Million	433,607 Added 23.7%	2,263,067 $327 Million

Q3 2024 Nov 12, 2024	BUY	$145.48 - $167.38 $5.14 Million - $5.92 Million	35,340 Added 1.97%	1,829,460 $296 Million
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $3.67 Million - $4.01 Million	-25,415 Reduced 1.4%	1,794,120 $262 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $12.2 Million - $12.8 Million	-78,543 Reduced 4.14%	1,819,535 $288 Million
Q4 2023 Feb 07, 2024	SELL	$145.6 - $158.88 $20.7 Million - $22.6 Million	-142,234 Reduced 6.97%	1,898,078 $298 Million
Q3 2023 Nov 07, 2023	SELL	$155.75 - $174.48 $736 Million - $824 Million	-4,723,592 Reduced 69.84%	2,040,312 $318 Million
Q2 2023 Aug 10, 2023	SELL	$154.35 - $166.11 $128 Million - $138 Million	-830,591 Reduced 10.94%	6,763,904 $1.12 Billion
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $163 Million - $195 Million	-1,079,581 Reduced 12.45%	7,594,495 $1.18 Billion
Q4 2022 Feb 07, 2023	SELL	$160.2 - $179.79 $58.8 Million - $65.9 Million	-366,795 Reduced 4.06%	8,674,076 $1.53 Billion
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $2.51 Million - $2.79 Million	-15,555 Reduced 0.17%	9,040,871 $1.48 Billion
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $116 Million - $129 Million	692,096 Added 8.27%	9,056,426 $1.61 Billion
Q1 2022 May 10, 2022	BUY	$158.14 - $179.59 $60.7 Million - $68.9 Million	383,705 Added 4.81%	8,364,330 $1.48 Billion
Q4 2021 Feb 04, 2022	BUY	$155.93 - $173.01 $27.3 Million - $30.3 Million	174,936 Added 2.24%	7,980,625 $1.37 Billion
Q3 2021 Nov 05, 2021	BUY	$161.5 - $179.47 $13.6 Million - $15.2 Million	84,423 Added 1.09%	7,805,689 $1.26 Billion
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $59.8 Million - $64.2 Million	375,005 Added 5.1%	7,721,266 $1.27 Billion
Q1 2021 May 10, 2021	BUY	$153.07 - $170.48 $12.7 Million - $14.2 Million	83,279 Added 1.15%	7,346,261 $1.21 Billion
Q4 2020 Feb 04, 2021	BUY	$137.11 - $157.38 $55 Million - $63.1 Million	400,945 Added 5.84%	7,262,982 $1.14 Billion
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $133 Million - $146 Million	949,327 Added 16.06%	6,862,037 $1.02 Billion
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $72.6 Million - $87.6 Million	-563,499 Reduced 8.7%	5,912,710 $832 Million
Q1 2020 May 13, 2020	BUY	$111.14 - $153.99 $484 Million - $671 Million	4,358,424 Added 205.8%	6,476,209 $849 Million
Q4 2019 Feb 05, 2020	SELL	$127.5 - $146.44 $37.8 Million - $43.5 Million	-296,786 Reduced 12.29%	2,117,785 $309 Million
Q3 2019 Nov 20, 2019	SELL	$126.95 - $142.14 $1 Billion - $1.12 Billion	-7,902,956 Reduced 76.6%	2,414,571 $312 Million
Q3 2019 Nov 08, 2019	SELL	$126.95 - $142.14 $30.7 Million - $34.3 Million	-241,526 Reduced 2.29%	10,317,527 $1.44 Billion
Q2 2019 Aug 26, 2019	SELL	$131.15 - $144.24 $78,558 - $86,399	-599 Reduced 0.01%	10,559,053 $1.47 Billion
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $247 Million - $271 Million	-1,881,619 Reduced 15.12%	10,559,652 $1.47 Billion
Q1 2019 May 03, 2019	SELL	$125.72 - $139.79 $5.73 Million - $6.37 Million	-45,568 Reduced 0.36%	12,441,271 $1.74 Billion
Q4 2018 Feb 07, 2019	SELL	$122.84 - $147.84 $66.5 Million - $80.1 Million	-541,478 Reduced 4.16%	12,486,839 $1.61 Billion
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $39.9 Million - $46.9 Million	328,260 Added 2.58%	13,028,317 $1.8 Billion
Q2 2018 Aug 03, 2018	SELL	$119.4 - $131.76 $10 Million - $11 Million	-83,852 Reduced 0.66%	12,700,057 $1.54 Billion
Q1 2018 May 04, 2018	BUY	$125.1 - $148.14 $651 Million - $771 Million	5,207,124 Added 68.72%	12,783,909 $1.64 Billion
Q4 2017 Feb 01, 2018	BUY	$131.22 - $143.62 $2.19 Million - $2.4 Million	16,723 Added 0.22%	7,576,785 $1.06 Billion
Q3 2017 Nov 02, 2017	BUY	$129.47 - $135.38 $979 Million - $1.02 Billion	7,560,062	7,560,062 $983 Million

Others Institutions Holding JNJ

# of Institutions

4,824

Shares Held

1.74B

Call Options Held

19.8M

Put Options Held

16.8M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $522B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.

Account